Robert E. Sell, Group Chief Exec-Com, Med & Technology at Accenture plc (ACN), sold 5,300 shares at $162.79 ($861K) on 2018-07-02, disclosed to the SEC on 2018-07-03.
Seasonal sale ($861k) by Group Chief Exec-Com, Med & Technology — this insider has traded ACN in July in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $162.02 | 2,200 | $356K | 41.4% |
| 2 | $162.79 | 1,550 | $252K | 29.3% |
| 3 | $162.79 | 1,550 | $252K | 29.3% |
| Total | $162.47 avg | 5,300 | $861K | 100% |
| Filing → |
| ACN | SELL | 2017-10-03 | $469K | — | Filing → |
| ACN | SELL | 2017-06-27 | $369K | — | Filing → |
| ACN | SELL | 2017-04-28 | $329K | — | Filing → |